Abstract
INTRODUCTION The study aimed to compare cognitive trajectories between patients with reports of social isolation and loneliness and those without.
METHODS Reports of social isolation, loneliness, and Montreal Cognitive Assessment (MoCA) scores were extracted from dementia patients’ medical records using Natural Language Processing models and analysed using mixed-effects models.
RESULTS Lonely patients (n = 382), compared to controls (n = 3912), showed an average MoCA score that was 0.83 points lower throughout the disease (p = 0.008). Socially isolated patients (n = 523) experienced a 0.21 MoCA points per year faster rate of cognitive decline in the six months before diagnosis (p = 0.029), but were comparable to controls before this period. This led to average MoCA scores that were 0.69 MoCA points lower at diagnosis (p = 0.011).
DISCUSSION Lower cognitive levels in lonely and socially isolated patients suggest that these factors may contribute to dementia progression.
Competing Interest Statement
IK is a paid medical advisor to Five Lives, a digital healthcare company developing a platform for addressing preventable risk factors for dementia in ageing adults. All other authors declare no conflicts of interest.
Funding Statement
This study was supported by CRIS Powered by Akrivia Health, using data, systems and support from the NIHR Oxford Health Biomedical Research Centre (NIHR203316) Research Informatics Team. IK is funded through MRC, NIHR Oxford Health Biomedical Research Facility and an investigator-initiated grant by Novo Nordisk.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Application Review Board of the University of Sheffield gave ethical approval for this work (ID: 045869).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This version has been updated following reviewer comments. The main updates include: clarification of findings in the abstract to improve interpretation of results; additional full cohort details in the text and Table 2; minor changes to Table 3 to improve interpretability; added additional discussion regarding real-world context and impact of study findings; added additional discussion regarding limitations to using secondary data; updated research in context document to reflect changes. The title has also been amended to better reflect the focus of the study.
Data Availability
All patient data used in the present study are accessible through the UK-CRIS system. The source data for this work is owned by Oxford Health NHS Foundation Trust using anonymised patient records via CRIS Powered by Akrivia Health. The data cannot be made publicly available but can be accessed with permissions from Oxford Health NHS Foundation Trust for UK NHS staff and UK academics within a secure firewall, in the same manner as the authors. The R and Python code used to analyse the data and develop NLP models is reported in supporting materials.
